StemoniX Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $115K

  • Investors
  • 3

StemoniX General Information

Description

Developer of a human-induced cardiac screening platform designed to improve and accelerate the process of neurotoxicity research and drug screening. The company's platform creates new cell-based disease models, and operationalizes custom human induced pluripotent stem cells (iPSC) disease models at a large scale for high-throughput screening, enabling scientists to economically conduct research with improved outcomes in a simplified workflow.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Parent Company
Corporate Office
  • 13300 67th Avenue North
  • Maple Grove, MN 55311
  • United States
+1 (855) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

StemoniX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Later Stage VC 01-Jun-2021 $115K 00000 Completed Generating Revenue
14. Merger/Acquisition 30-Mar-2021 000.00 000.00 000.00 Completed Generating Revenue
13. Later Stage VC 01-Jan-2021 00.000 000.00 0000 Completed Generating Revenue
12. Debt - PPP 10-Apr-2020 00000 000.00 Completed Generating Revenue
11. Later Stage VC (Series B) 23-Oct-2019 000.00 000.00 Completed Generating Revenue
10. Later Stage VC 11-Oct-2019 00.000 000.00 Completed Generating Revenue
9. Early Stage VC 06-Sep-2018 00.000 000.00 Completed Generating Revenue
8. Early Stage VC (Series A) 10-Mar-2017 00.000 00.000 Completed Generating Revenue
7. Seed Round 06-Oct-2016 $2.5M $5.92M Completed Generating Revenue
6. Accelerator/Incubator 03-Oct-2016 $80K $3.42M Completed Generating Revenue
To view StemoniX’s complete valuation and funding history, request access »

StemoniX Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a human-induced cardiac screening platform designed to improve and accelerate the process of neurotoxicity
Biotechnology
Maple Grove, MN
13 As of 2023
00000
0000000000 0 00000

000000

e dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla p
0000000000000
Dublin, OH
0 As of 0000
000
0000000000 000

000000

sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labo
0000000000000
Cambridge, United Kingdom
00 As of 0000
000.00
00.00 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

StemoniX Competitors (36)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nanofiber Solutions Venture Capital-Backed Dublin, OH 0 000 0000000000 000
DefiniGEN Venture Capital-Backed Cambridge, United Kingdom 00 000.00 00000000000 000.00
Sernova Corporation London, Canada 00 000.00 000000000 000.00
Hesperos Venture Capital-Backed Orlando, FL 00 00000000
iXCells Biotechnologies Private Equity-Backed San Diego, CA 00 0000000 0000
You’re viewing 5 of 36 competitors. Get the full list »

StemoniX Patents

StemoniX Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3918056-A1 Method of using human spheroids for drug discovery Pending 02-Feb-2019 00000000000
AU-2020216980-A1 Method of using human spheroids for drug discovery Inactive 02-Feb-2019 00000000000
JP-2023090807-A Method of using human spheroids for drug discovery Pending 02-Feb-2019 00000000000
AU-2024200581-A1 Method of using human spheroids for drug discovery Pending 02-Feb-2019 00000000000
US-20190085296-A1 Method of expansion of human pancreas progenitor cells from stem cells using feeder-conditioned media Inactive 20-Sep-2017 C12N5/0678
To view StemoniX’s complete patent history, request access »

StemoniX Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

StemoniX Former Investors (21)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
701 Fund Angel Group Minority 000 0000 000000 0
Alumni Ventures Venture Capital Minority 000 0000 000000 0
Brightstone Venture Capital Venture Capital Minority 000 0000 000000 0
Catalytic Impact Foundation Not-For-Profit Venture Capital Minority 000 0000 000000 0
Chestnut Street Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 21 investors. Get the full list »

StemoniX Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Joint Venture (StemoniX and Atomwise) 03-Dec-2019 00000 0000 Drug Discovery 0000-0000
To view StemoniX’s complete investments history, request access »

StemoniX Subsidiaries (1)

Company Name Industry Location Founded
StemoniX (MicroBrain Technology) Buildings and Property Maple Grove, MN
To view StemoniX’s complete subsidiaries history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »